Profile data is unavailable for this security.
About the company
Embecta Corp. is a global diabetes care company. It is focused on providing solutions to people living with diabetes. It has a portfolio of products, including a range of pen needles, syringes and safety injection devices, which are complemented by its digital application designed to assist people with managing their diabetes. Its pen needles are sterile, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. In addition to pen needles, it sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It has clearance from the FDA for its proprietary disposable insulin delivery system, which is indicated for adults who require insulin to manage diabetes, including both type 1 (T1D) and type 2 (T2D).
- Revenue in USD (TTM)1.12bn
- Net income in USD69.70m
- Incorporated2021
- Employees2.20k
- LocationEmbecta Corp300 Kimball Drive, Suite 300PARSIPPANY NJ 07054United StatesUSA
- Phone+1 (862) 401-0000
- Fax+1 (302) 655-5049
- Websitehttps://www.embecta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AxoGen Inc | 173.48m | -16.54m | 642.98m | 426.00 | -- | 6.72 | -- | 3.71 | -0.3829 | -0.3829 | 4.01 | 2.18 | 0.9117 | 1.62 | 7.43 | 407,237.10 | -8.69 | -13.92 | -9.93 | -15.84 | 76.98 | 79.74 | -9.53 | -20.28 | 2.32 | -2.94 | 0.3297 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
| Simulations Plus Inc | 66.98m | 9.65m | 645.45m | 192.00 | 68.05 | 3.57 | 45.64 | 9.64 | 0.474 | 0.474 | 3.29 | 9.04 | 0.3603 | -- | 5.57 | 348,843.80 | 5.19 | 7.20 | 5.49 | 7.61 | 72.53 | 77.61 | 14.40 | 21.29 | -- | -- | 0.00 | 45.70 | 10.52 | 14.96 | -20.20 | 6.02 | 12.91 | 0.8548 |
| SI-Bone Inc | 150.71m | -40.85m | 660.02m | 344.00 | -- | 3.99 | -- | 4.38 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
| Mesa Laboratories Inc | 223.71m | -250.31m | 694.70m | 736.00 | -- | 4.61 | -- | 3.11 | -46.43 | -46.43 | 41.43 | 27.87 | 0.4131 | 2.51 | 6.29 | 303,956.50 | -46.23 | -9.20 | -50.62 | -9.88 | 62.27 | 60.60 | -111.89 | -28.33 | 1.37 | 1.33 | 0.5848 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
| Cytek Biosciences Inc | 197.71m | -17.56m | 695.66m | 645.00 | -- | 1.79 | -- | 3.52 | -0.1327 | -0.1327 | 1.49 | 2.96 | 0.392 | 1.54 | 4.19 | 292,470.40 | -3.48 | -- | -3.89 | -- | 54.97 | -- | -8.88 | -- | 6.38 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
| Orthopediatrics Corp | 175.07m | -25.12m | 707.30m | 247.00 | -- | 1.91 | -- | 4.04 | -1.10 | -1.10 | 7.65 | 15.33 | 0.4045 | 0.4286 | 4.61 | 708,793.50 | -5.80 | -5.40 | -6.43 | -5.93 | 74.62 | 75.09 | -14.35 | -15.92 | 1.96 | -44.23 | 0.0261 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
| Standard Biotools Inc | 136.30m | -164.66m | 783.14m | 534.00 | -- | 1.53 | -- | 5.75 | -0.9018 | -0.9018 | 0.6606 | 1.37 | 0.2561 | 2.25 | 5.73 | 255,243.50 | -22.29 | -28.17 | -26.55 | -33.60 | 46.67 | 51.58 | -87.05 | -74.85 | 3.53 | -- | 0.0974 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
| Castle Biosciences Inc | 287.59m | -3.10m | 846.80m | 610.00 | -- | 2.00 | 84.79 | 2.94 | -0.1346 | -0.1346 | 10.45 | 15.30 | 0.6302 | 7.38 | 7.44 | 471,457.40 | -0.6791 | -9.43 | -0.7383 | -10.17 | 81.86 | 80.58 | -1.08 | -28.46 | 7.92 | -- | 0.0238 | -- | 60.38 | 57.35 | 14.41 | -- | 117.94 | -- |
| Alphatec Holdings Inc | 540.28m | -180.91m | 872.26m | 839.00 | -- | 51.90 | -- | 1.61 | -1.34 | -1.34 | 4.00 | 0.2847 | 0.7736 | 1.13 | 7.30 | 643,959.50 | -25.90 | -30.97 | -33.24 | -39.47 | 69.44 | 66.02 | -33.48 | -46.22 | 1.21 | -4.59 | 0.9273 | -- | 37.45 | 39.38 | -23.36 | -- | 67.92 | -- |
| Embecta Corp | 1.12bn | 69.70m | 906.50m | 2.20k | 13.02 | -- | 8.37 | 0.8102 | 1.21 | 1.21 | 19.36 | -13.24 | 0.8882 | 2.11 | 11.60 | 508,590.90 | 5.53 | -- | 7.91 | -- | 66.42 | -- | 6.23 | -- | 1.61 | 2.06 | 1.88 | -- | -0.7703 | -- | -68.52 | -- | -- | -- |
| Bioventus Inc | 536.89m | -41.96m | 938.48m | 1.03k | -- | 6.22 | -- | 1.75 | -0.6595 | -0.6595 | 8.48 | 1.86 | 0.6591 | 1.95 | 4.18 | 553,495.90 | -6.70 | -5.52 | -9.65 | -7.27 | 66.53 | 68.25 | -10.16 | -10.94 | 0.956 | 1.08 | 0.6697 | -- | 0.0445 | 9.93 | 6.91 | -- | 23.51 | -- |
| Figs Inc | 550.80m | 18.68m | 961.94m | 354.00 | 54.72 | 2.39 | 43.12 | 1.75 | 0.1029 | 0.1029 | 3.04 | 2.35 | 1.18 | 1.23 | 58.02 | 1,555,932.00 | 3.99 | -- | 4.65 | -- | 68.02 | -- | 3.39 | -- | 3.89 | -- | 0.00 | -- | 7.87 | -- | 6.85 | -- | -- | -- |
| Artivion Inc | 376.97m | -8.32m | 1.05bn | 1.50k | -- | 3.56 | 70.16 | 2.79 | -0.2076 | -0.2076 | 9.11 | 7.06 | 0.481 | 1.67 | 5.44 | 251,316.00 | -1.07 | -2.20 | -1.15 | -2.36 | 64.63 | 65.51 | -2.22 | -5.34 | 4.04 | 1.07 | 0.5177 | -- | 12.82 | 6.14 | -60.09 | -- | 5.13 | -- |
| Avanos Medical Inc | 682.40m | 7.00m | 1.13bn | 3.77k | 161.12 | 0.9277 | 21.73 | 1.66 | 0.1532 | 0.1671 | 14.71 | 26.62 | 0.4105 | 1.93 | 5.20 | 180,960.00 | 0.4211 | -0.6527 | 0.4737 | -0.7338 | 55.82 | 54.45 | 1.03 | -1.60 | 1.49 | 7.06 | 0.1253 | -- | -1.58 | 0.6357 | -146.05 | -- | -18.37 | -- |
| Pulse Biosciences Inc | 0.00 | -44.02m | 1.15bn | 56.00 | -- | 38.36 | -- | -- | -0.7916 | -0.7916 | 0.00 | 0.4883 | 0.00 | -- | -- | 0.00 | -76.43 | -93.21 | -84.97 | -104.99 | -- | -- | -- | -12,332.25 | -- | -- | 0.00 | -- | -100.00 | -- | 27.85 | -- | -15.20 | -- |
Data as of Sep 19 2024. Currency figures normalised to Embecta Corp's reporting currency: US Dollar USD
61.92%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2024 | 8.32m | 14.42% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 7.17m | 12.42% |
| River Road Asset Management LLCas of 30 Jun 2024 | 3.58m | 6.21% |
| Millennium Management LLCas of 30 Jun 2024 | 3.44m | 5.97% |
| American Century Investment Management, Inc.as of 30 Jun 2024 | 3.16m | 5.48% |
| Yacktman Asset Management LPas of 30 Jun 2024 | 2.82m | 4.88% |
| Fidelity Management & Research Co. LLCas of 30 Jun 2024 | 2.41m | 4.18% |
| SSgA Funds Management, Inc.as of 30 Jun 2024 | 2.32m | 4.03% |
| Geode Capital Management LLCas of 30 Jun 2024 | 1.34m | 2.33% |
| Charles Schwab Investment Management, Inc.as of 30 Jun 2024 | 1.16m | 2.01% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
